World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
24379
World Ranking
16638
National Ranking
873

Overview

Alfred Reiter is affiliated with the University of Giessen in Germany and focuses their research primarily within the field of medicine. Their work spans several specialized subfields, including pathology and forensic medicine, neurology, oncology, public health, environmental and occupational health, and pulmonary and respiratory medicine.

The scientist's main research topics cover an array of areas related to cancer and hematologic diseases, specifically:

  • Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia research
  • Sarcoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • CAR-T cell therapy research
  • Childhood Cancer Survivors' Quality of Life

Reiter's recent published papers illustrate their contribution to pediatric oncology and lymphoma treatment research. Notable works include:

  • "Prognostic Factors in Childhood Anaplastic Large Cell Lymphoma: Long Term Results of the International ALCL99 Trial" (2020) published in Cancers
  • "Progressive or Relapsed Burkitt Lymphoma or Leukemia in Children and Adolescents after BFM-type First-line Therapy" (2020) published in Blood
  • "Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial" (2020) published in Journal of Clinical Oncology
  • "Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group" (2020) published in Haematologica
  • "Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma" (2023) published in The Lancet Haematology

Their frequent coauthors indicate collaboration across multiple studies, including:

  • Andishe Attarbaschi
  • Wilhelm Woessmann
  • Birgit Burkhardt
  • Wolfram Klapper
  • Grażyna Wróbel

The regular publication venues in which Reiter's work appears are diverse but focused on hematology and oncology-oriented journals, including:

  • Cancers
  • Blood
  • Journal of Clinical Oncology
  • Haematologica
  • The Lancet Haematology

The research represents a sustained engagement with pediatric lymphomas and related malignancies, examining diagnostic, therapeutic, and long-term survivor outcomes. Their work also intersects with broader public health concerns and neurological aspects within oncology research. No record of book publications or awards is currently noted in their profile.

Best Publications

  • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

    Martin Schrappe;Alfred Reiter;Wolf-Dieter Ludwig;Jochen Harbott

  • Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86

    A Reiter;M Schrappe;WD Ludwig;W Hiddemann

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

    M Schrappe;A Reiter;M Zimmermann;J Harbott

  • Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    A Möricke;M Zimmermann;A Reiter;G Henze

  • Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

    Mitchell S. Cairo;Bertrand Coiffier;Alfred Reiter;Anas Younes

  • Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Alfred Reiter;Martin Schrappe;Markus Tiemann;Wolf-Dieter Ludwig

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.

    Michael Dördelmann;Alfred Reiter;Arndt Borkhardt;Wolf-Dieter Ludwig

  • Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.

    Alfred Reiter;Martin Schrappe;Wolf-Dieter Ludwig;Markus Tiemann

  • The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

    Wilhelm Woessmann;Kathrin Seidemann;Georg Mann;Martin Zimmermann

  • Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.

    A Reiter;M Schrappe;R Parwaresch;G Henze

  • Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

    Karl Welte;Cornelia Zeidler;Alfred Reiter;Wolfgang Müller

  • Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Kathrin Seidemann;Markus Tiemann;Martin Schrappe;Elif Yakisan

  • The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.

    Birgit Burkhardt;Martin Zimmermann;Ilske Oschlies;Felix Niggli

  • Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.

    Lutz Löning;Martin Zimmermann;Alfred Reiter;Peter Kaatsch

  • Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

    J. Maurer;E. Thiel;W.-D. Ludwig;J.W.G. Janssen

  • Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.

    Ursula Creutzig;M. Zimmermann;J. Ritter;D. Reinhardt

  • High Cure Rates and Reduced Long-Term Toxicity in Pediatric Hodgkin's Disease: The German-Austrian Multicenter Trial DAL-HD-90

    Günther Schellong;Richard Pötter;Jürgen Brämswig;Wolfgang Wagner

  • Diagnostic Cerebrospinal Fluid Examination in Children With Acute Lymphoblastic Leukemia: Significance of Low Leukocyte Counts With Blasts or Traumatic Lumbar Puncture

    Britta Bürger;Martin Zimmermann;Georg Mann;Joachim Kühl

Frequent Co-Authors

Martin Zimmermann
Martin Zimmermann Hannover Medical School
Martin Schrappe
Martin Schrappe Kiel University
Helmut Gadner
Helmut Gadner St Anna Children's Hospital
Wolfram Klapper
Wolfram Klapper Kiel University
Karl Welte
Karl Welte University of Tübingen
Günter Henze
Günter Henze Charité - University Medicine Berlin
Jochen Harbott
Jochen Harbott University of Giessen
Laurence Brugières
Laurence Brugières Institut Gustave Roussy
Charlotte M. Niemeyer
Charlotte M. Niemeyer University of Freiburg
Martin Stanulla
Martin Stanulla Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible pathways, a variety of adn to fnp bridge programs allow registered nurses with an associate degree to advance their education and become family nurse practitioners. These programs are typically tailored to working nurses and can be pursued online.

If you have an interest in preventive care or community health, earning an online bachelor's in nutrition can open doors to roles in wellness, education, and specialized clinical settings. This degree is suitable for those passionate about promoting healthy lifestyles.

For those leaning towards healthcare leadership, consider online mha programs cahme accredited. These programs provide advanced training in healthcare administration, preparing graduates for management and executive positions in hospitals and public health organizations.

Finally, online rn to bsn programs without clinical requirements are an excellent way for nurses to earn a bachelor's degree without additional in-person responsibilities. Whether you aim for direct patient care or a leadership track, these flexible online options can help you advance your medical career.

Best Scientists Citing Alfred Reiter

Trending Scientists

Recently Published Articles